Skip to main content
Vatche Tchekmedyian, MD, Oncology, South Portland, ME

VatcheTchekmedyianMD

Oncology South Portland, ME

Physician

Dr. Tchekmedyian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Tchekmedyian's full profile

Already have an account?

  • Office

    265 Western Ave
    South Portland, ME 04106
    Phone+1 207-661-0200
    Fax+1 207-661-0299

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2019
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2011 - 2014
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 2011

Certifications & Licensure

  • ME State Medical License
    ME State Medical License 2019 - 2025
  • NY State Medical License
    NY State Medical License 2016 - 2020
  • MA State Medical License
    MA State Medical License 2014 - 2017
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • A retrospective analysis of cisplatin dosing strategies when used with radiation on outcomes in head and neck squamous cell carcinoma of the oropharynx. 
    2019 ASCO Annual Meeting - 6/1/2019
  • A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic adenoid cystic carcinoma (R/M ACC). 
    2019 ASCO Annual Meeting - 6/1/2019
  • A phase II study of lenvatinib in patients with progressive, recurrent/metastatic adenoid cystic carcinoma. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018